NattoPharma Signs Agreement with Nutriangels, Expands MenaQ7 Brazil Presence

63387064-1aac-4b69-9b6a-a39c0cd6cf5darticleimage.jpg

16 Jun 2017 --- NattoPharma has announced a new partnership with Nutriangels, a Brazilian nutraceutical brand with products that include chelated minerals, further expanding the presence of MenaQ7 Vitamin K2 as MK-7 in Brazil. The company reports that Nutriangels launched K2 + featuring MenaQ7 in Q2 2017, adding that the product has already been well received. K2 + is positioned to support both bone and cardiovascular health. 

“Brazil is a burgeoning market where NattoPharma already enjoys an established presence. Nutriangels is one of the new pioneering supplement brands serving Brazil and we are thrilled to see this new customer expand our MenaQ7 offering with consumer-targeted, science-based products,” says Eric Anderson, Senior Vice President of Global Sales and Marketing with NattoPharma. 

Click to Enlarge“This milestone marks a welcome increase in awareness of the importance of Vitamin K2 for human health, and the global recognition that MenaQ7 is the clinically validated branded Vitamin K2 as MK-7 of choice,” Anderson says. 

Earlier this week, NattoPharma highlighted the results of a study on the link between low vitamin K2 status and increased risk of fracture in children.

“NattoPharma's clinical trials with adult and child populations have shown that children have the greatest need for vitamin K2, as their bones are growing and developing so intensely, and [the trials have] confirmed that just 45mcg daily of MenaQ7 Vitamin K2 had a profound impact on children's bone health,” Kate Quackenbush, NattoPharma’s Director of Communications, told NutritionInsight.

Regarding the application opportunities for K2, Quackenbush says the company’s “ultimate goal is to see MenaQ7 Vitamin K2 as MK-7 as a core nutrient in all multivitamins, but in particular for kids and prenatal multis that provide a sound foundation for health as early as possible.”

“From a claims perspective, in Europe, due to EFSA regulations, health claims must be applied for and awarded. We are hopeful that this will occur in the coming years. However, given EFSA's recent performance, this is yet to be seen,” she adds.

“In other parts of the world, the regulatory guidelines are different. Regardless, one must have scientific substantiation in the body of evidence that validates the claim. NattoPharma has extensive research including in vitro, in vivo and 16 published human studies (with more underway), that clearly demonstrate the mechanism of vitamin K2 and the subsequent real health benefits such as preserving bone health and mass, and preserving arterial flexibility,” Quackenbush states.

Related Articles

Nutrition & Health News

Food for the heart (Part 2): Consumer trends and innovations

19 Oct 2017 --- Food for heart health is a key trend in nutrition NPD, with many companies exploring ways in which to protect consumers against cardiovascular issues. Today, in the second part of a special report, NutritionInsight examines which consumer trends are driving innovation in the world of heart health products and what these innovations are.

Nutrition & Health News

Vitamin D activation pathways in inflammation and bone health uncovered

17 Oct 2017 --- Researchers have identified a region of the genome that regulates vitamin D activation in the kidneys, opening the door for more sophisticated treatments of diseases, including bone and immune disorders, involving vitamin D. The results of this research will be published in the October 20 issue of the Journal of Biological Chemistry.

Nutrition & Health News

Spotting the trends: Nexira explores natural ingredients with sought-after health benefits

16 Oct 2017 --- FODMAP friendly, vegan and flexitarian are no longer small niche markets; they are significant trends and their “claims” are being required more and more by end consumers in the US, the EU and the rest of the world. This is according to Julie Imperato, Nexira’s Marketing Manager.

Nutrition & Health News

Food for the heart (Part 1): Opportunities, challenges and delivery forms

16 Oct 2017 --- Heart health is literally a matter of life and death – according to the US Centers for Disease Control and Prevention (CDC), about 610,000 people die of heart disease in the US every year. This means that it accounts for 1 in every 4 deaths. Indeed, heart disease is the leading cause of death for both men and women, so potential nutritional solutions are at the forefront of companies’ thinking.

Nutrition & Health News

Dietary potassium may protect against calcification of arteries

10 Oct 2017 --- Foods that are rich in potassium, such as bananas and avocados, may help protect against pathogenic vascular calcification, also known as hardening of the arteries. This is according to University of Alabama at Birmingham researchers who have shown that reduced dietary potassium promotes elevated aortic stiffness in a mouse model, as compared with normal-potassium-fed mice. Such arterial stiffness in humans is predictive of heart disease and death from heart disease, and it represents an important health problem for the nation as a whole.

More Articles
URL : http://www.nutritioninsight.com:80/news/nattopharma-signs-agreement-with-nutriangels-expands-menaq7-brazil-presence.html